ereprof. dr. Rudi Dierckx
Show
Sort by
-
SPECT and PET in eating disorders
-
Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?
-
In vivo evaluation of 1-O-(4-(2-fluoroethyl-carbamoyloxymethyl)-2-nitrophenyl)-O-β-D-glucopyronuronate : a positron emission tomographic tracer for imaging β-glucuronidase activity in a tumor/inflammation rodent model
-
The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression
-
[18F]FDG Labeling of neural stem cells for in vivo cell tracking with positron emission tomography: inhibition of tracer release by phloretin
-
PET Imaging of estrogen receptors as a diagnostic tool for breast cancer patients presenting with a clinical dilemma
-
Clinical indications to the use of 99mTc-EDDA/HYNIC-TOC to detect somatostatin receptor-positive neuroendocrine tumors
-
PET and MRI for the evaluation of regional myocardial perfusion and wall thickening after myocardial infarction
-
In vivo evaluation of [18F]FEAnGA-Me: a PET tracer for imaging β-glucuronidase (β-GUS) activity in a tumor/inflammation rodent model
-
In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice